This is a classic PIVOT story. READ BETWEEN THE LINES.
The irony is that they believe the new indication will likely be a very successful market for them and worth Pursuing above the current IIH trajectory. I think, given they can effectively skip the que with safety trials, that a pivot is being signalled by the company as a preferred direction.
The secondary indication was being Pursued AS the trial was failing. They saw the writing on the wall. As soon as it was approved, they spilled the beans. Short term pain for LT gain.
There will be a spill, a CEO change and new direction.
I believe, that in the future, this will be seen as a master stroke.
This is a classic PIVOT story. READ BETWEEN THE LINES. The irony...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable